Induced Pluripotent Stem (iPS) Cell Lines
Showing 1 - 25 of >10,000
Cell Collection to Study Eye Diseases
Recruiting
- Retinal Disease
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Preparation of Patient Autologous Induced Pluripotent Stem
Not yet recruiting
- Age-Related Macular Degeneration
- somatic cell collection
- (no location specified)
Aug 14, 2023
Acute Ischemic Stroke Trial (exosomes derived from human induced pluripotent stem cell for injection, a of exosomes derived
Not yet recruiting
- Acute Ischemic Stroke
- exosomes derived from human induced pluripotent stem cell for injection
- a placebo of exosomes derived from human induced pluripotent stem cell for injection
- (no location specified)
Nov 15, 2023
Inherited Cardiac Arrythmias, Long QT Syndrome (LQTS), Brugada Syndrome (BrS) Trial in Baltimore
Enrolling by invitation
- Inherited Cardiac Arrythmias
- +9 more
-
Baltimore, MarylandJohns Hopkins Medical Institute
Jan 5, 2023
Atopic Dermatitis Trial in Beijing (GD-iExo-001, normal saline)
Recruiting
- Atopic Dermatitis
- GD-iExo-001
- normal saline
-
Beijing, Beijing, ChinaChinese Academy of Medical Science & Peking Union Medical Colleg
Jul 23, 2023
Refractory Focal Epilepsy Trial in Beijing (iPSC-Exos)
Recruiting
- Refractory Focal Epilepsy
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 5, 2023
Age-Related Macular Degeneration Trial run by the NEI (iPSC-derived RPE/PGLA transplantation)
Recruiting
- Age-Related Macular Degeneration
- iPSC-derived RPE/PLGA transplantation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 28, 2023
Ischemic Heart Failure, Chronic Heart Failure Trial in Changsha, Nanjing (Human (allogeneic) iPS-cell-derived cardiomyocyte)
Not yet recruiting
- Ischemic Heart Failure
- Chronic Heart Failure
- Human (allogeneic) iPS-cell-derived cardiomyocyte
-
Changsha, Hunan, China
- +1 more
Oct 12, 2022
Glioblastoma, GBM Trial in Suzhou (XS005 Cell Injection, Temozolomide(TMZ))
Recruiting
- Glioblastoma
- GBM
- XS005 Cell Injection
- Temozolomide（TMZ）
-
Suzhou, Jiangsu, ChinaDushu Lake Hospital Affiliated to Soochow University
Nov 23, 2023
Genetic Basis for Neurological Disease by Genetic Screening
Enrolling by invitation
- Neuro-Degenerative Disease
- Genechip screening kit
-
Hong Kong, Shatin, Hong KongPrince of Wales Hospital
Sep 29, 2021
Heart Failure, Ischemic Heart Disease Trial in Kawasaki, Tokyo (HS-001 CS, HS-001-D needle, HS-001-D Adaptor)
Recruiting
- Heart Failure
- Ischemic Heart Disease
- HS-001 CS
- HS-001-D needle, HS-001-D Adaptor
-
Kawasaki, Japan
- +8 more
Nov 17, 2022
Macular Degeneration Trial in Beijing (Autologous iPSC-derived RPE)
Recruiting
- Macular Degeneration
- Autologous iPSC-derived RPE
-
Beijing, Beijing, ChinaBeijing Tongren Hospitol,Capital Medical University
Jun 30, 2022
Knee Osteoarthritis Trial (NCR100 injection)
Not yet recruiting
- Knee Osteoarthritis
- NCR100 injection
- (no location specified)
Sep 19, 2023
Stem Cells in NF1 Tumors of the Central Nervous System
Suspended
- Neurofibromatosis Type 1
- Tumors of the Central Nervous System
- Collection of Stem Cells
-
Washington, District of ColumbiaChildren's National Medical Center
Mar 8, 2022
Severe Asthma, Allergic Bronchopulmonary Aspergillosis (ABPA) Trial in Montpellier (Blood sample)
Recruiting
- Severe Asthma
- Allergic Bronchopulmonary Aspergillosis (ABPA)
- Blood sample
-
Montpellier, Franceuniversity Hospital of Montpellier
Dec 2, 2022
Production of iPSC Derived RPE Cells for Transplantation in AMD
Completed
- Age Related Macular Degeneration (AMD)
- (no location specified)
Apr 4, 2022
Best Disease and Other Retinal Degenerative Diseases.
Active, not recruiting
- Retinal Disease
- +4 more
-
Rochester, MinnesotaMayo Clinic
Jan 4, 2022
Structural Chromosome Rearrangements and Brain Disorders
Enrolling by invitation
- Rare Diseases
- +2 more
-
Stockholm, SwedenAnna Lindstrand
Oct 2, 2023
Generation of Heart Muscle Cells From Blood or Skin Cells of
Recruiting
- Breast Cancer
- skin punch biopsy
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 1, 2022
iPS Cell Manufacture and Banking Trial (Whole Blood Donation)
Terminated
- iPS Cell Manufacture and Banking
- Whole Blood Donation
- (no location specified)
Jul 14, 2020
Fibroblast-Derived Cell Lines From Skin Biopsies of
Enrolling by invitation
- Primary Immunodeficiency
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 18, 2023
Derivation of Induced Pluripotent Stem Cells FromExisting
Recruiting
- Amyotrophic Lateral Sclerosis
-
Jerusalem, Israel
- +1 more
Feb 13, 2022
Generation of Induced Pluripotent Stem Cell Lines From Skin
Completed
- AMD
-
Beverly Hills, California
- +13 more
Apr 3, 2019
Induced Pluripotent Stem Cells for Development of Novel Drug
Recruiting
- Inborn Errors of Metabolism
- Skin biopsy
- Withdraw of blood
-
Lahore, PakistanChildren Hospital and Institute of Child Health
May 14, 2021
Existing Fibroblast Cells to Convert to Induced Pluripotent Stem
Recruiting
- Pregnant, Healthy Females
- Healthy Male Newborns
-
Jerusalem, IsraelHadassah Ein Kerem
Feb 13, 2022